Company to develop AMG 714 for the treatment of diet non-responsive celiac disease and refractory celiac disease (celiac disease-triggered T-cell lymphoma).
02/23/2015Emerging therapeutic company to initially focus on addressing the significant medical and socioeconomic needs of patients with celiac disease
02/17/2015Although more research is needed, larazotide acetate may work better than the gluten-free diet alone in some patients.
11/21/2014Research Offers Benchmark of T Cell Reactivity by Comparing Side-by-Side Reactions to Barley and Oats in Celiac Disease Patients
05/13/2014Many people with celiac disease have significant disease-associated symptoms and intestinal damage despite trying to adhere to a strict gluten-free diet.
04/14/2014Researchers have discovered that a human protein called elafin may be helpful in protecting against the inflammatory reaction seen in people with celiac disease.
02/11/2014Alba Therapeutics Corporation provides an update on their investigational medication, larazotide acetate.
01/17/2014Alvine Pharmaceuticals, Inc. provides an update on a clinical trial investigating a potential medication for celiac disease.
08/21/2013Fusion Antibodies Ltd have announced a collaboration with Swiss biotech company Calypso Biotech for development of their CALY-002 Antibody.
08/12/2013Study seeks to learn more about the relationship between the autoimmune diseases and the underlying cause of type 1 diabetes.
06/10/2013Joseph Murray, MD of the Mayo Clinic explains the potential pharmaceutical treatments for celiac disease.
05/14/2013AbbVie secures exclusive option to acquire global rights to ALV003, which has the potential to be the first therapy to treat celiac disease.
04/22/2013Celiac disease research could lend insight to other autoimmune diseases.
09/06/2012Alvine Pharmaceuticals' ALV003 is being developed as a treatment for celiac disease in conjunction with a gluten-free diet.
09/04/2012ImmusanT announced the initiation of clinical trials for the investigational vaccine, Nexvax2.
08/13/2012Researchers released the clinical trial results for the investigational medication, larazotide acetate.
05/01/2012New questionnaire, the first of its kind, will be used to evaluate investigational compound in patients with celiac.
01/19/2012Purpose of study is to determine safety and effectiveness of investigational medication for individuals with celiac disease.
12/13/2011Vaccine designed to allow celiac disease patients to return to normal gluten containing diet.
10/11/2011Participants who took ALV300 had fewer symptoms and less intestinal damage than placebo group after 6-week gluten challenge.
05/10/2011Immunotherapeutic vaccine is designed to reduce the body's rejection of gluten, according to renowned researcher and NFCA Medical Advisory Board member Dr. Bob Anderson.
04/21/2011Survey of 310 patients found vaccine is at top of wish list.
03/11/2011Avaxia Biologics received $145,000 in funding to develop an “anti-gluten antibody.”
Newer Posts 1 2 3 4 5 Older Posts
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
